close

Fundraisings and IPOs

1 2 3 4 73
Number of results: 1449
Date Company Amount Funding type Investors Therapeutic area Type of Information
2018-09-06 Allogene Therapeutics (USA - CA) $120 Million financing round Cancer - Oncology Financing round
2018-09-05 Retrophin (USA - CA) $240 million private placement Rare diseases Private placement
2018-08-31 Antabio (France) € 12.5 million series A financing round iXO Private Equity (France) IRDI SORIDEC Gestion (France) Galia Gestion (France) Omnes Capital (France) BNP Paribas Développement (France) Sham Innovation Santé (Turenne Capital) (France) and company’s historical investors including former President of OM Pharma Christophe Ricard. Rare diseases - Infectious diseases Series A financing round
2018-08-16 Krystal Biotech (USA - PA) $10 million private placement Frazier Healthcare Partners (USA - WA) Rare diseases - Genetic diseases Private placement
2018-08-13 Orchard Therapeutics (UK) $150 Million series C financing round ArrowMark Partners (USA - CO) Cormorant Asset Management (USA - MA) Foresite Capital (USA - NY) RA Capital Management (USA - MA) Perceptive Advisors (USA - NY) RTW Investments (USA - NY) Venrock (USA - CA) Foresite Capital (USA - NY) Sphera Global Healthcare (Spain) Medison Ventures Driehaus Capital Management (USA - IL) Ghost Tree Capital Group (USA - NY) Temasek (Singpore) Baillie Gifford (UK) Cowen Healthcare (USA - NY) Agent Capital (USA - MA) Rare diseases - Genetic diseases Series C financing round
2018-08-08 Beigene (China) $903 million IPO Cancer - Oncology IPO
2018-08-06 Pharmaxis (Australia) A$24 million (£13.4 million - €15.35 million) financing round Arix Bioscience (UK) BVF Partners (USA - CA) other existing shareholders Fibrotic diseases - Inflammatory diseases Financing round
2018-08-03 Drug Discovery Gateway Investment Limited Partnership - DDG Fund (Japan) financing round Takeda Pharmaceutical (Japan) Whiz Partners (Japan) Financing round
2018-07-31 AC Immune (Switzerland) $117.5 million private placement Neurological diseases - CNS diseases Private placement
2018-07-28 Bluebird Bio (USA - MA) $550 million private placement Rare diseases - Genetic diseases Private placement
2018-07-23 Azafaros (The Netherlands) seed financing round BioGeneration Ventures (The Netherlands) Rare diseases - Genetic diseases - Metabolic diseases Financing round
2018-07-23 OliX Pharmaceuticals (South Korea) KRW43 billion ($38 million) IPO Fibrotic diseases - Ophtalmological diseases IPO
2018-07-06 Oncologie (USA - MA - China) $16.5 million seed financing round Nan Fung Life Sciences (China) Pivotal bioVenture Partners China Fund (China) China Merchant Bank Investments (China) Volcanics Ventures (China) Cancer - Oncology Financing round
2018-06-28 Innovation Pharmaceuticals (USA - MA) $7 million private placement Aspire Capital (USA - IL) Cancer - Oncology - Infectious diseases Private placement
2018-06-25 Avrobio (USA - MA) $114.7 million IPO Cancer - Oncology - Rare diseases - Genetic diseases - Lysosomal diseases IPO
2018-06-25 Akero Therapeutics (USA - MA) $65 Million series A financing round Apple Tree Partners (USA - NY) Atlas Venture (USA - MA) venBio Partners (USA - CA) Versant Ventures (USA - CA) Liver diseases - Hepatic diseases Series A financing round
2018-06-12 MeiraGTx (USA - NY) $75 million private placement Rare diseases - Genetic diseases Private placement
2018-05-30 Iontas (UK) £556 000 ($737 000) grant Innovate UK (UK) CNS diseases Grant
2018-05-29 Melinta Therapeutics (USA - CT) private placement Infectious diseases Private placement
2018-05-29 Mereo BioPharma (UK) private placement Rare diseases Private placement